Using Polidocanol in Treatment of Simple Renal Cyst

• Published in: Indian journal of surgery Vol. 82; no. 1; pp. 81 - 83
• Main Authors: Guner, Bayram, Gunaydin, Bilal
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01-02-2020; Springer; Springer Nature B.V
• Subjects: Cardiac Surgery; Care and treatment; Comorbidity; Cysts; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Neurosurgery; Older people; Original Article; Pediatric Surgery; Plastic Surgery; Surgery; Thoracic Surgery; Percutaneous therapy; Renal cyst; Sclerotherapy; Minimally invasive treatment
• ISSN: 0972-2068; 0973-9793
• DOI: 10.1007/s12262-019-01964-7

The aim of this study was to assess the efficacy of polidocanol in patients with simple renal cysts who were not eligible for surgery due to comorbidities. Twenty-nine patients with Bosniak type 1 or 2 were assessed retrospectively. All of the cysts were exophytic. All of the patients were injected a maximum 20 mL 3% polidocanol as a sclerosing agent following cyst aspiration. Vanishing of symptoms and decrease in size to 10% of the initial size were accepted as complete remission, decrease in size to 10–50% of the initial size was accepted as partial remission, and a return to the initial size of the cyst in a short time or decrease in size > 50% of the initial size was accepted as failure. The results of an average of 14 months’ follow-up are reported. Complete remission was seen in 18 (62%) patients, partial remission was seen in 5 (17.2%) patients, and failure was observed in 6 (20.68%) patients during an average of 14 months’ follow-up. Percutaneous sclerotherapy using polidocanol can be used safely and with low complication rates in the elderly population with comorbidities.